ICU Medical Quick Ratio 2006-2019 | ICUI

Historical quick ratio values for ICU Medical (ICUI) over the last 10 years.
ICU Medical Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-03-31 $0.60B $0.24B 2.51
2018-12-31 $0.62B $0.25B 2.47
2018-09-30 $0.62B $0.20B 3.07
2018-06-30 $0.61B $0.20B 3.02
2018-03-31 $0.57B $0.20B 2.88
2017-12-31 $0.58B $0.21B 2.74
2017-09-30 $0.59B $0.20B 3.01
2017-06-30 $0.50B $0.19B 2.66
2017-03-31 $0.44B $0.16B 2.74
2016-12-31 $0.52B $0.04B 12.82
2016-09-30 $0.45B $0.03B 13.90
2016-06-30 $0.49B $0.04B 11.95
2016-03-31 $0.47B $0.03B 13.71
2015-12-31 $0.46B $0.04B 10.83
2015-09-30 $0.47B $0.04B 12.71
2015-06-30 $0.43B $0.03B 15.09
2015-03-31 $0.42B $0.03B 12.66
2014-12-31 $0.40B $0.03B 13.77
2014-09-30 $0.39B $0.03B 13.21
2014-06-30 $0.38B $0.03B 13.82
2014-03-31 $0.36B $0.03B 14.28
2013-12-31 $0.36B $0.03B 13.38
2013-09-30 $0.33B $0.03B 12.18
2013-06-30 $0.31B $0.03B 11.06
2013-03-31 $0.30B $0.03B 11.64
2012-12-31 $0.29B $0.03B 9.93
2012-09-30 $0.28B $0.03B 9.51
2012-06-30 $0.26B $0.03B 8.61
2012-03-31 $0.24B $0.03B 9.40
2011-12-31 $0.22B $0.03B 7.51
2011-09-30 $0.19B $0.02B 8.05
2011-06-30 $0.19B $0.03B 7.08
2011-03-31 $0.17B $0.03B 6.22
2010-12-31 $0.16B $0.03B 6.26
2010-09-30 $0.15B $0.03B 5.70
2010-06-30 $0.14B $0.03B 4.57
2010-03-31 $0.14B $0.03B 4.65
2009-12-31 $0.17B $0.03B 4.95
2009-09-30 $0.17B $0.02B 7.05
2009-06-30 $0.18B $0.02B 8.72
2009-03-31 $0.17B $0.02B 7.42
2008-12-31 $0.16B $0.02B 7.35
2008-09-30 $0.16B $0.02B 7.24
2008-06-30 $0.15B $0.02B 6.98
2008-03-31 $0.14B $0.02B 6.69
2007-12-31 $0.13B $0.02B 6.23
2007-09-30 $0.14B $0.02B 7.03
2007-06-30 $0.16B $0.02B 7.78
2007-03-31 $0.15B $0.02B 9.78
2006-12-31 $0.16B $0.02B 9.75
2006-09-30 $0.15B $0.02B 8.35
2006-06-30 $0.14B $0.02B 8.37
2006-03-31 $0.13B $0.01B 9.07
2005-12-31 $0.12B $0.01B 8.81
2005-09-30 $0.11B $0.01B 7.90
2005-06-30 $0.10B $0.01B 7.22
2005-03-31 $0.12B $0.01B 13.33
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.103B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.825B 29.16
Medtronic (MDT) Ireland $135.913B 19.41
Stryker (SYK) United States $78.520B 28.02
Boston Scientific (BSX) United States $59.297B 28.43
Baxter (BAX) United States $42.385B 26.71
EssilorLuxottica Societe Anonyme (ESLOY) France $29.267B 0.00
Coloplast (CLPBY) Denmark $25.937B 41.41
Zimmer Biomet Holdings (ZBH) United States $25.411B 16.33
Lonza Group Ag (LZAGY) Switzerland $25.385B 0.00
Terumo (TRUMY) Japan $21.889B 25.17
Smith & Nephew SNATS (SNN) United Kingdom $19.108B 0.00
ResMed (RMD) United States $17.890B 34.18
Canopy Growth (CGC) Canada $12.379B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.239B 48.98
Insulet (PODD) United States $7.299B 531.83
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Hill-Rom Holdings (HRC) United States $7.083B 21.47
Aurora Cannabis (ACB) Canada $7.048B 69.50
Perrigo (PRGO) Ireland $6.991B 11.82
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.299B 51.41
GW Pharmaceuticals (GWPH) United Kingdom $5.007B 0.00
Neogen (NEOG) United States $3.388B 55.09
NuVasive (NUVA) United States $3.018B 24.64
Agios Pharmaceuticals (AGIO) United States $2.894B 0.00
Hutchison China MediTech (HCM) China $2.829B 0.00
National Vision Holdings (EYE) United States $2.507B 53.42
Quidel (QDEL) United States $2.307B 23.94
Aphria (APHA) $1.619B 0.00
Cardiovascular Systems (CSII) United States $1.549B 889.60
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.216B 0.00
VAREX IMAGING (VREX) United States $1.171B 24.86
NanoString Technologies (NSTG) United States $1.107B 0.00
Lantheus Holdings (LNTH) United States $1.086B 28.83
PetIQ (PETQ) United States $1.002B 24.33
Quanterix (QTRX) United States $0.820B 0.00
Cerus (CERS) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.35
Omeros (OMER) United States $0.760B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
TG Therapeutics (TGTX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.608B 29.43
Surmodics (SRDX) United States $0.538B 78.24
OraSure Technologies (OSUR) United States $0.525B 24.17
Meridian Bioscience (VIVO) United States $0.492B 15.03
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.465B 0.00
Vapotherm (VAPO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.324B 22.45
BioLife Solutions (BLFS) United States $0.319B 99.82
Cytosorbents (CTSO) United States $0.246B 0.00
Zynex (ZYXI) United States $0.239B 24.60
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.186B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.167B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.139B 7.32
Female Health (VERU) United States $0.138B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.25
MRI INTERVENTNS (MRIC) United States $0.052B 0.00